Author:
Dong YiJie,Zhan WeiWei,Zhou JianQiao,Li Ning,Liu ZhenHua,Xia ShuJun,Ni XiaoFeng,Liu Juan,Zhang JingWen,Xu ShangYan,Yang ZhiFang,Hua Qing
Funder
Academician Expert Workstation of Yunnan Province
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference19 articles.
1. Baloch ZW, Asa SL, Barletta JA et al (2022) Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 33:27–63
2. Yang W, Fananapazir G, LaRoy J, Wilson M, Campbell MJ (2020) Can the American Thyroid Association, K-Tirads, and Acr-Tirads ultrasound classification systems be used to predict malignancy in Bethesda category IV nodules? Endocr Pract 26:945–952
3. Li F, Pan D, Wu Y et al (2019) Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule. Diagn Cytopathol 47:881–889
4. Ibrahim Y, Mohamed SE, Deniwar A et al (2015) The impact of thyroid nodule size on the risk of malignancy in follicular neoplasms. Anticancer Res 35:1635–1639
5. Zahid A, Shafiq W, Nasir KS et al (2021) Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective. J Clin Transl Endocrinol 23:100250
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献